ClinicalTrials.Veeva

Menu

The Dual Impact of Cirrhosis on Transplantation for Hepatocellular Carcinoma:a Two-center Retrospective Cohort Study in China

X

Xiao Xu

Status

Completed

Conditions

Cirrhosis
Hepatocellular Carcinoma

Study type

Observational

Funder types

Other

Identifiers

NCT06420791
CT2024-ZJU-OBS9

Details and patient eligibility

About

Background: This study aims to investigate the correlation between cirrhosis and hepatocellular carcinoma (HCC) recurrence after Liver Transplantation.

Methods: The study retrospectively collected data enrolled from 519 HCC patients who underwent liver transplantation from two center(the First Affiliated Hospital, Zhejiang University School of Medicine and Shulan (Hangzhou) Hospital, January 2015 to December 2020), Based on important variables, 1:3 propensity score matching (PSM) were performed respectively.

Enrollment

1 patient

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

The patients undergoing liver transplantation for HCC from January 2015 to December 2020.

Exclusion criteria

Re-transplantation or combined liver-kidney transplantation; incomplete laboratory or clinical data; death within 90 days.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems